Labcorp Holdings Inc (LH) Stock News

While Wall Street analysts maintain a bullish average brokerage recommendation (ABR) of 1.59 for Celsius Holdings with 16 Strong Buy ratings, the article cautions that brokerage recommendations often have positive bias due to vested interests. The Zacks Rank system, which relies on earnings estimate revisions, rates CELH as a Strong Sell (#5) due to a 7.5% decline in consensus earnings estimates over the past month to $1.47, suggesting near-term downside risk.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

Law firm Lowey Dannenberg is investigating Alignment Healthcare (ALHC) for potential federal securities violations following allegations by a former executive that the company manipulated finances by misclassifying $8-10 million in operating expenses as capital expenditures to artificially inflate adjusted EBITDA. The disclosure caused Alignment's stock to fall 16.7% on July 8, 2026.

Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) following a whistleblower complaint alleging accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the disclosure.

Hagens Berman is investigating Alignment Healthcare, Inc. (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to artificially inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Law firm Kaplan Fox is investigating Alignment Healthcare for alleged accounting irregularities where millions in operating expenses were misclassified as capital expenditures, artificially inflating financial metrics including Adjusted EBITDA. The stock fell 16.7% on July 8, 2026, following the whistleblower complaint disclosure.

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities by misclassifying operating expenses as capital expenditures to inflate EBITDA and financial results for 2024-2025. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Hagens Berman is investigating Alignment Healthcare (ALHC) following whistleblower allegations that the company engaged in accounting irregularities, misclassifying operating expenses as capital expenditures to inflate EBITDA and financial metrics. The disclosure caused ALHC stock to plunge 16.7% in a single day, marking its worst performance since February 2024.

Block & Leviton is investigating Alignment Healthcare, Inc. (ALHC) for potential securities law violations following allegations that a former executive filed a whistleblower lawsuit claiming the company manipulated finances to boost stock price and executive compensation. The stock fell approximately 16.72% following the report. The firm is also investigating Jefferies Financial Group and Unicycive Therapeutics for similar violations.

Law firm Johnson Fistel announced an investigation into Alignment Healthcare (NASDAQ: ALHC) following a whistleblower lawsuit filed by a former executive alleging the company manipulated its finances to boost stock price and executive compensation. The firm is investigating whether the company complied with federal securities laws and is seeking investors who suffered losses.

Pomerantz LLP is investigating potential securities fraud claims against Celsius Holdings following a Texas Attorney General investigation into whether the company and its subsidiary Alani Nutrition misrepresented the safety of high-caffeine energy drinks marketed to children and teens. The announcement triggered a 7.53% stock price decline on June 4, 2026.

Joseph Konowiecki, vice chairman of Alignment Healthcare, sold 25,000 shares on June 26 for $575,000, reducing his direct holdings by 2.2%. While the sale aligns with his historical trading pattern and occurs under a pre-filed trading plan, the timing coincides with his recent step down from chairman and follows a pattern of executive selling over the past year. However, insider sales are predictive of stock declines less than half the time, and investors should weigh this against other company fundamentals.

Vishay Intertechnology expanded its ILHB series of automotive-grade ferrite beads with smaller case sizes (0402-1206), higher current capability up to 6 A, and wider impedance range (10 Ω to 2700 Ω). The enhanced product line delivers 2-3x current capability for the same package size and includes improved datasheets with additional design parameters. Samples and production quantities are available with 8-10 week lead times.

Valhi, Inc. (NYSE: VHI) announced a regular quarterly dividend of $0.08 per share payable on June 25, 2026. At its annual stockholder meeting on May 21, 2026, shareholders elected six directors for one-year terms and approved executive compensation on an advisory basis. The board appointed Randy L. Hill to fill a vacancy resulting from W. Hayden McIlroy's death in April.

The Schall Law Firm is investigating Norwegian Cruise Line Holdings Ltd. (NCLH) for potential securities law violations related to false or misleading statements. The investigation was prompted by the company's Q1 2026 financial results released on May 4, 2026, which included lowered full-year guidance for adjusted EPS, causing shares to fall more than 29.3% on the same day.